View a financial market summary for IOBT including stock price quote, trading volume, volatility, options volume, statistics, and other important company. Over the last year, IO Biotech shares have traded in a share price range of $ to $ IO Biotech currently has 65,, shares outstanding. The. View the IOBT premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the IO Biotech Inc real. The latest IO Biotech stock prices, stock quotes, news, and IOBT history to help you invest and trade smarter. IO Biotech, Inc. (US:IOBT) has 29 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These.
IO Biotech, Inc. (8prestigespin.ru): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock IO Biotech, Inc. | Nasdaq: IOBT | Nasdaq. IO Biotech is a clinical-stage biopharmaceutical company pioneering the first dual-action immune-modulating cancer vaccine. IO Biotech Inc IOBT:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date01/05/24 · 52 Week Low · 52 Week. IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating therapeutic cancer vaccines based on the T-win technology platform. Instrument Name Io Biotech Inc Instrument Symbol (IOBT-Q). Instrument Exchange NASDAQ ; Average Volume , ; Price/Earnings (TTM) ; Forward Annual. View IO Biotech (IOBT) stock price, news, historical charts, analyst ratings, financial information and quotes on Moomoo. Trade commission-free with the. The average price target is $ with a high forecast of $ and a low forecast of $ The average price target represents a % change from the. IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. Find the latest analyst research, reports, and ratings for IO Biotech, Inc. Common Stock (IOBT) at 8prestigespin.ru Which stock exchange are IO Biotech shares traded on and what is the company's ticker? IO Biotech Inc. analyst ratings, historical stock prices, earnings estimates & actuals. IOBT updated stock price target summary.
The Wall Street analyst predicted that Io Biotech's share price could reach $ by Aug 14, The average Io Biotech stock price prediction forecasts a. Price, $, Volume, 1,, Change, , % Change, %. Today's Open, $, Previous Close, $ Intraday High, $, Intraday Low, $ IO Biotech's shares are traded on the Nasdaq Global Market under the symbol “IOBT”. When did IO Biotech go public? IO Biotech, Inc. (8prestigespin.ru): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock IO Biotech, Inc. | Nasdaq: IOBT | Nasdaq. Discover real-time IO Biotech, Inc. Common Stock (IOBT) stock prices, quotes, historical data, news, and Insights for informed trading and investment. 52 Week Range · Open Price $ · Previous Close $ · Volume IO Biotech Inc Share Price. Over the last year, IO Biotech, Inc.'s stock price has decreased by %. IO Biotech, Inc. is currently approximately $ per share. View the latest IO Biotech Inc. (IOBT) stock price, news, historical charts, analyst ratings and financial information from WSJ. Is IO Biotech (NASDAQ:IOBT) In A Good Position To Invest In Growth? (Simply Wall St.) Mar AM.
IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating cancer therapies based on the T-win technology platform. IO Biotech, Inc. engages in the development of immune modulating cancer therapies based on its T-win technology platform. Its platform is a novel approach to. IOBT - IO Biotech, Inc. (NasdaqGS) - Share Price and News. View a financial market summary for IOBT including stock price quote, trading volume, volatility, options volume, statistics, and other important company. IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating therapeutic cancer vaccines based on the T-win technology platform.
View the latest IOBT share price or buy & sell IO Biotech stock on NASDAQ using Lightyear. IO Biotech Inc is a clinical-stage biopharmaceutical company. Stock Price Forecast. The 2 analysts with month price forecasts for IO Biotech stock have an average target of 11, with a low estimate of 10 and a high. 52 Week Range · Open Price $ · Previous Close $ · Volume IO Biotech Inc Share Price.